HOME >> BIOLOGY >> NEWS
DOE JGI releases IMG 1.5 with curated archaeal genomes

WALNUT CREEK, CA--Version 1.5 of the Integrated Microbial Genomes (IMG) data management system of the U.S. Department of Energy Joint Genome Institute (DOE JGI) has been released to the public. IMG 1.5 now contains a total of 741 genomes (435 bacterial, 32 archaeal, 15 eukaryotic genomes and 259 bacterial phages) of which 602 are finished and 139 are draft genomes.

IMG 1.5 contains 62 finished and 100 draft genomes sequenced by DOE JGI, bringing this total to 162 microbial genomes generated in-house. Compared to the previous release, IMG 1.5 contains 38 new (17 finished, 21 draft) DOE JGI genomes and 21 new public microbial genomes.

Among the challenges in genomics remains the determination of the precise location of genes from DNA sequence information. DOE JGI has embarked on curating the gene models of microbial genomes culled from public sources. Towards this goal, IMG 1.5 now contains 22 archaeal genomes with curated gene models and detailed documentation of the methodology and standards employed for achieving this goal. A separate IMG Curated Archaeal Genomes data mart (http://img.jgi.doe.gov/archaeal_qa/) contains these genomes with their corresponding original genomes from the public domain, and allows the examination of gene model changes by comparing each curated gene model with the original.

IMG 1.5 extensions include the addition of IMG terms (which are curated protein products) and IMG pathways to characterize genes. Also, users are now able to enter their own product name for a gene directly through the gene details page and to propagate this annotation to selected paralogs, orthologs, and homologs of the gene. User interface extensions include such enhanced comparative analysis capabilities as gene profiles across genomes. For more details on the user interface, see What's New (http://img.jgi.doe.gov/pub/doc/release
'"/>


Contact: David Gilbert
gilbert21@llnl.gov
925-296-5643
DOE/Joint Genome Institute
27-Jun-2006


Page: 1 2

Related biology news :

1. Journal of Nuclear Medicine releases new research faster
2. DOE JGI releases enhanced Genome Data Management System IMG 2.1 marking 2-year anniversary
3. National panel led by LSU Chancellor releases report on Corps of Engineers
4. AAAS releases video and first board consensus statement on climate change
5. DOE JGI releases IMG 2.0 with all genomes refreshed from RefSeq
6. NSET releases document: EHS research needs for engineered nanoscale materials
7. DOE JGI sequences, releases genome of symbiotic tree fungus
8. DOE JGI releases experimental metagenomics data management & analysis system
9. DOE JGI releases fourth version of IMG in 2005
10. Center releases new public survey on stem cells
11. DOE JGI releases latest version of IMG

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: DOE JGI releases IMG with curated archaeal genomes

(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ... beliefs about the condition and the best ways to treat ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ... accuracy is the ultimate driver in long-term mass consumer ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
(Date:12/19/2014)... , Dec. 18, 2014  Decision Resources Group ... dental biomaterial market will grow moderately through 2023 as ... and growing awareness of dental biomaterials all spur procedure ... such as China and ... bring dental procedures within reach for a larger proportion ...
(Date:12/17/2014)... The Activated Carbon Manufacturing industry ... IBISWorld updated its original industry research report. , ... intensified focus on environmental policy. Over the five years ... power plants and a range of other industrial facilities ... Sarah Kahn, “a range of downstream industrial sectors rely ...
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
Breaking Biology Technology:iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
Cached News: